The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.
read more
Source: NY Times
00:57, May 27, 2021
Jan Hoffman and Mary Williams Walsh